Daniel Jones

Daniel Jones is a Principal Scientist at invoX Pharma, leading the Translational Science of the FS222 project. Prior to this role, Daniel worked as a Senior Scientist at F-star Therapeutics, Inc., where Daniel was also involved in the Translational Development of the FS222 bispecific clinical project. With a background in Biotechnology from Oxford Brookes University and a Bachelor's degree in Human Biology from Loughborough University, Daniel has extensive experience in translational science and in vitro assays for clinical projects.